Aktis Oncology earnings were N/A for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest AKTS earnings report on Sep 30, 2025 announced Q3 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AKTS reported annual earnings of -$44.0M, with 53.6% growth.
AKTS earnings history
Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%
AKTS Return on Equity
Insufficient data to display
AKTS Return on Assets
Insufficient data to display
Be the first to know when AKTS announces earnings.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.